Factor VIIa, Recombinant
Recombinant factor VIIa is a blood clotting factor that is used in hemophiliac patients, particularly those who are currently bleeding due to trauma. Hemophilia is a rare but serious blood disease in which a person’s blood does not clot. Even minor cuts and injuries can cause the hemophiliac person to bleed for hours. Patients receive recombinant factor VIIa via injections. The injection is repeated several times; dosing frequency depends on how severe the person’s condition is.
This medication can cause headaches, nausea, vomiting and dizziness. These symptoms are usually not severe, but you should tell your doctor if they are unusually intense.
Some people are highly allergic to this drug. Allergic reactions can be fatal and require immediate medical attention. Symptoms of allergic reaction include hives or rashes, swelling of the face, throat or tongue and difficulty breathing.